Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Senior pentester | Job DetailsDo you want to participate in advanced offensive security assessments? The GMV Technical Audits team is looking for you!We like to get straight to the point and tell you what you wont